首页 | 本学科首页   官方微博 | 高级检索  
     

膈下逐瘀汤合六君子汤治疗乙肝肝硬化临床观察
引用本文:李璐璐,柳忠全. 膈下逐瘀汤合六君子汤治疗乙肝肝硬化临床观察[J]. 光明中医, 2022, 37(2): 250-253. DOI: 10.3969/j.issn.1003-8914.2022.02.025
作者姓名:李璐璐  柳忠全
作者单位:黄河科技学院附属医院检验科 河南 郑州 450000;黄河科技学院附属医院中医科 河南 郑州 450000
摘    要:目的 探讨膈下逐瘀汤合六君子汤对乙肝肝硬化患者肝纤维化及炎症-氧化应激指标的影响.方法 选择黄河科技学院附属医院感染性疫痛科2019年6月—2020年6月收治的61例乙肝肝硬化患者作为研究对象,将其分为观察组(31例)和对照组(30例),分组方法为随机摸球法.对照组采用常规西药进行治疗,观察组在对照组基础上增加膈下逐瘀...

关 键 词:膈下逐瘀汤  六君子汤  乙肝  肝硬化  肝纤维化指标

Clinical Observation on Gexia Zhuyu Decoction and Liujunzi Decoction in the Treatment of Hepatitis B Cirrhosis
LI Lulu,LIU Zhongquan. Clinical Observation on Gexia Zhuyu Decoction and Liujunzi Decoction in the Treatment of Hepatitis B Cirrhosis[J]. Journal of Traditional Chinese Medicine, 2022, 37(2): 250-253. DOI: 10.3969/j.issn.1003-8914.2022.02.025
Authors:LI Lulu  LIU Zhongquan
Affiliation:(Department of Laboratory Medicine,Affiliated Hospital of Huanghe University of Science and Technology,Henan Province,Zhengzhou 450000,China;Department of Traditional Chinese Medicine,Affiliated Hospital of Huanghe University of Science and Technology,Henan Province,Zhengzhou 450000,China)
Abstract:Objective To investigate the effects of Gexia Zhuyu decoction and Liujunzi decoction on liver fibrosis and inflammation-oxidative stress indicators in patients with hepatitis B cirrhosis. Methods 61 patients with hepatitis B cirrhosis admitted in the department of infectious diseases of Affiliated Hospital of Huanghe University of Science and Technology from June 2019 to June 2020 were selected as the research objects,and they were divided into observation group( n = 31) and control group( n = 30). Grouping method is a random touch ball method. The control group was treated with conventional western medicine. The observation group added Gexia Zhuyu decoction and Liujunzi decoction on the basis of the control group. The clinical efficacy,the liver fibrosis indexes and inflammation-oxidative stress indicators was compared. Results The effective rate of the observation group( 93. 55%) was higher than that of the control group( 73. 33%),and the difference between the groups was significant( P = 0. 04). After treatment,the expression level of liver fibrosis indexes in the observation group was lower than that in the control group,and the difference between the groups was significant( P < 0. 05). After treatment,the inflammation-oxidative stress indicators in the observation group included interleukin-2( IL-2),malondialdehyde( MDA),reactive oxygen species( ROS),interleukin-β( IL-1β),and total antioxidant capacity the expression level of( T-AOC) was lower than that of the control group,and the levels of superoxide dismutase( SOD) and glutathione peroxidase( GSH-Px) were higher than those of the control group,and there had significant differences between the groups( P < 0. 05). Conclusion Gexia Zhuyu decoction and Liujunzi decoction have certain application value in patients with hepatitis B liver cirrhosis,which can improve the therapeutic effect,improve the inflammation-oxidative stress state,and improve the degree of liver fibrosis.
Keywords:Gexia Zhuyu decoction  Liujunzi decoction  hepatitis B  liver cirrhosis  liver fibrosis index
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号